BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16823004)

  • 1. Potential consequences of the pneumococcal conjugate vaccine.
    Kopterides P; Falagas ME
    N Engl J Med; 2006 Jul; 355(1):95; author reply 95-6. PubMed ID: 16823004
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children.
    Xue L; Yao K; Xie G; Zheng Y; Wang C; Shang Y; Wang H; Wan L; Liu L; Li C; Ji W; Xu X; Wang Y; Xu P; Liu Z; Yu S; Yang Y
    Clin Infect Dis; 2010 Mar; 50(5):741-4. PubMed ID: 20113175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coming of age of niche vaccines? Effect of vaccines on resistance profiles in Streptococcus pneumoniae.
    McGee L
    Curr Opin Microbiol; 2007 Oct; 10(5):473-8. PubMed ID: 17936680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The volatile nature of pneumococcal serotype epidemiology: potential for misinterpretation.
    Black S
    Pediatr Infect Dis J; 2010 Apr; 29(4):301-3. PubMed ID: 19935444
    [No Abstract]   [Full Text] [Related]  

  • 5. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
    Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
    Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal vaccine--direct and indirect ("herd") effects.
    Musher DM
    N Engl J Med; 2006 Apr; 354(14):1522-4. PubMed ID: 16598050
    [No Abstract]   [Full Text] [Related]  

  • 7. Pneumococcal resistance in the postvaccine era.
    Temime L; Guillemot D; Boƫlle PY
    Pediatr Infect Dis J; 2006 Apr; 25(4):382-3. PubMed ID: 16568001
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promises and challenges of pneumococcal conjugate vaccines for the developing world.
    Grijalva CG; Edwards KM
    Clin Infect Dis; 2006 Sep; 43(6):680-2. PubMed ID: 16912938
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
    Dagan R
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial-resistant Streptococcus pneumoniae: trends and management.
    Jacobs MR
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):619-35. PubMed ID: 18847402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.
    Feikin DR; Klugman KP
    Clin Infect Dis; 2002 Sep; 35(5):547-55. PubMed ID: 12173128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotypes and antimicrobial resistance of streptococcus pneumoniae in Thailand 2002-2004.
    Levine S; Dejsirilert S; Sangsuk L; Chantra S; Feikin DR; Dowell SF; Olsen SJ
    Pediatr Infect Dis J; 2006 Feb; 25(2):176-8. PubMed ID: 16462300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights on pneumococcal disease: what we have learned over the past decade.
    Dagan R
    Vaccine; 2009 Aug; 27 Suppl 3():C3-5. PubMed ID: 19552985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines.
    Prymula R
    Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media.
    Joloba ML; Windau A; Bajaksouzian S; Appelbaum PC; Hausdorff WP; Jacobs MR
    Clin Infect Dis; 2001 Nov; 33(9):1489-94. PubMed ID: 11588694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Empyema: bacterial epidemiology and antibiotic resistance].
    Vu-Thien H
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S81-3. PubMed ID: 19000860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization--in HIV-Infected and HIV-uninfected children.
    Madhi SA; Adrian P; Kuwanda L; Cutland C; Albrich WC; Klugman KP
    J Infect Dis; 2007 Dec; 196(11):1662-6. PubMed ID: 18008250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004.
    Paraskakis I; Kafetzis DA; Chrisakis A; Papavasilliou H; Kirikou H; Pangalis A; Tzouvelekis LS; Athanasiou T; Legakis NJ;
    Clin Microbiol Infect; 2006 May; 12(5):490-3. PubMed ID: 16643530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.